Follow us on:

ECO Animal Health Group CEO David Hallas Delivering a Strong Set of Results (VIDEO)

ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the six months ended 30 September 2023.

David talks us through the highlights, the growth in revenues for China, Japan, USA & Canada, the improved cash position, what the approval of Aivlosin® from the US FDA and Veterinary Drugs Directorate in Canada means for the company, the markets and impact on ECO and the outlook for the company and its R&D pipeline.

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets.

Find more news, interviews, share price & company profile here for:Eco Animal Health Group plc

Share this interview

Other Interviews

More News

ECO Animal Health Group receives marketing authorisation from Brazil’s Ministry of Agriculture January 7, 2021
ECO Animal Health Group revenue ahead of management expectations October 21, 2020
ECO Animal Health Group receives European positive opinion for Avilosin in pigs May 26, 2020
ECO Animal Health Group Receives marketing authorisation from Ministry of Agriculture January 30, 2020
ECO Animal Health enter worldwide exclusive research partnership with The Pirbright Institute September 4, 2019
ECO Animal Health Group plc receives marketing authorisation for Aivlosin® in chickens laying eggs for human consumption. March 5, 2019

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.